Form 4: BioCardia CEO Peter Altman Acquires Shares and Settles Restricted Stock Units

Peter Altman, CEO of BioCardia, acquired shares through vested restricted stock units and had shares withheld for tax obligations.

Summary

• On October 11, 2024, Peter Altman, the President and CEO of BioCardia, Inc., acquired 44,250 shares of common stock at $2.65 per share through the vesting of restricted stock units (RSUs).
• These RSUs were awarded as compensation in lieu of cash and vested 100% on the same date.
• Also on October 11, 2024, 21,680 shares were withheld by BioCardia at $2.65 per share to satisfy income tax obligations related to the RSU settlement.
• Following these transactions, Altman directly owns 103,981 shares of BioCardia common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of shares through RSU vesting is mildly positive, but the tax withholding is a neutral event.

Positives

• The acquisition of shares by the CEO, even through RSU vesting, can be seen as a positive sign of confidence in the company.

Negatives

• The withholding of shares for tax obligations reduces the net increase in the CEO's holdings.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates changes in the CEO's ownership of BioCardia stock.

Stakeholder Impact

• Shareholders may view the CEO's increased stake as a positive signal.
• Employees may see the RSU vesting as a standard part of the compensation package.

Key Dates

Keywords

BioCardia, Peter Altman, Form 4, Beneficial Ownership, Restricted Stock Units, BCDA, CEO, Shares